Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: LUNA LABS USA LLC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-03-10 to 2024-07-09
Current total value of award: $999994.61
Description: PER SECTION 711 OF THE 2019 NDAA, USARMAA TRANSFERRED TO DHA 10/1/2022. MEDICAL RESEARCH AND DEVELOPMENT CONTRACT ARMY STTR PH II A2-9117 TITLED LONG-TERM MALARIAL CHEMOPROPHYLACTIC DRUG RELEASING IMPLANT. TOPIC A18B-T002